![]() |
Balaji Amines Limited (Balamines.NS) Avaliação DCF
IN | Basic Materials | Chemicals - Specialty | NSE
|

- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Balaji Amines Limited (BALAMINES.NS) Bundle
Projetado para precisão, nossa calculadora DCF (Balaminesns) permite avaliar a avaliação da Balaji Amines Limited usando dados financeiros do mundo real, além de completa flexibilidade para modificar todos os parâmetros essenciais para projeções aprimoradas.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9,357.7 | 13,114.6 | 23,203.5 | 23,375.7 | 16,415.1 | 20,028.2 | 24,436.4 | 29,815.0 | 36,377.4 | 44,384.2 |
Revenue Growth, % | 0 | 40.15 | 76.93 | 0.74207 | -29.78 | 22.01 | 22.01 | 22.01 | 22.01 | 22.01 |
EBITDA | 1,858.7 | 3,794.1 | 6,359.1 | 6,241.3 | 3,531.2 | 4,983.4 | 6,080.3 | 7,418.6 | 9,051.5 | 11,043.7 |
EBITDA, % | 19.86 | 28.93 | 27.41 | 26.7 | 21.51 | 24.88 | 24.88 | 24.88 | 24.88 | 24.88 |
Depreciation | 317.3 | 345.2 | 405.2 | 453.5 | 453.7 | 499.6 | 609.6 | 743.8 | 907.5 | 1,107.3 |
Depreciation, % | 3.39 | 2.63 | 1.75 | 1.94 | 2.76 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 |
EBIT | 1,541.4 | 3,448.9 | 5,953.9 | 5,787.9 | 3,077.5 | 4,483.8 | 5,470.7 | 6,674.8 | 8,144.0 | 9,936.5 |
EBIT, % | 16.47 | 26.3 | 25.66 | 24.76 | 18.75 | 22.39 | 22.39 | 22.39 | 22.39 | 22.39 |
Total Cash | 518.1 | 173.2 | 381.3 | 3,085.1 | 3,306.2 | 1,675.9 | 2,044.8 | 2,494.9 | 3,044.0 | 3,714.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 2,074.4 | 3,081.1 | 5,881.5 | 3,778.0 | 3,194.0 | 4,271.1 | 5,211.2 | 6,358.2 | 7,757.7 | 9,465.2 |
Account Receivables, % | 22.17 | 23.49 | 25.35 | 16.16 | 19.46 | 21.33 | 21.33 | 21.33 | 21.33 | 21.33 |
Inventories | 1,104.4 | 1,099.4 | 2,223.6 | 3,028.1 | 2,957.1 | 2,432.9 | 2,968.4 | 3,621.7 | 4,418.9 | 5,391.5 |
Inventories, % | 11.8 | 8.38 | 9.58 | 12.95 | 18.01 | 12.15 | 12.15 | 12.15 | 12.15 | 12.15 |
Accounts Payable | 593.6 | 768.0 | 1,808.8 | 621.0 | 777.9 | 1,097.2 | 1,338.7 | 1,633.3 | 1,992.8 | 2,431.4 |
Accounts Payable, % | 6.34 | 5.86 | 7.8 | 2.66 | 4.74 | 5.48 | 5.48 | 5.48 | 5.48 | 5.48 |
Capital Expenditure | -601.4 | -1,319.8 | -1,482.0 | -1,202.2 | -2,637.2 | -1,765.9 | -2,154.6 | -2,628.8 | -3,207.4 | -3,913.4 |
Capital Expenditure, % | -6.43 | -10.06 | -6.39 | -5.14 | -16.07 | -8.82 | -8.82 | -8.82 | -8.82 | -8.82 |
Tax Rate, % | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 | 32.07 |
EBITAT | 1,232.1 | 2,515.3 | 3,793.1 | 3,324.0 | 2,090.6 | 3,066.4 | 3,741.3 | 4,564.7 | 5,569.4 | 6,795.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1,637.1 | 713.4 | -167.4 | 2,686.3 | 719.1 | 1,566.4 | 962.2 | 1,174.0 | 1,432.4 | 1,747.7 |
WACC, % | 10.14 | 10.13 | 10.12 | 10.11 | 10.12 | 10.12 | 10.12 | 10.12 | 10.12 | 10.12 |
PV UFCF | ||||||||||
SUM PV UFCF | 5,148.0 | |||||||||
Long Term Growth Rate, % | 3.00 | |||||||||
Free cash flow (T + 1) | 1,800 | |||||||||
Terminal Value | 25,269 | |||||||||
Present Terminal Value | 15,602 | |||||||||
Enterprise Value | 20,750 | |||||||||
Net Debt | -615 | |||||||||
Equity Value | 21,365 | |||||||||
Diluted Shares Outstanding, MM | 32 | |||||||||
Equity Value Per Share | 659.36 |
What You Will Receive
- Customizable Excel Template: A tailored Excel-based DCF Calculator featuring pre-filled financials for Balaji Amines Limited (BALAMINESNS).
- Comprehensive Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA percentage, and WACC to refine your analysis.
- Instant Calculations: Effortlessly observe how your inputs influence the valuation of Balaji Amines Limited (BALAMINESNS).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts who require precision.
- User-Centric Layout: Organized for ease of understanding and usability, complete with clear instructions for every step.
Key Features
- Customizable Forecast Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and additional metrics without delay.
- Industry-Leading Precision: Leverages Balaji Amines Limited’s (BALAMINESNS) real financial data for accurate valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and review outcomes side by side.
- Efficiency Booster: Say goodbye to the hassle of constructing intricate valuation models from the ground up.
How It Functions
- Download the Template: Gain immediate access to the Excel-based BALAMINESNS DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh to reflect Balaji Amines Limited's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation impacts.
- Analyze and Decide: Use the findings to inform your investment strategy or financial analysis.
Why Opt for This Calculator for Balaji Amines Limited (BALAMINESNS)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for BALAMINESNS.
- Adjustable Parameters: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Balaji Amines.
- Pre-Existing Data: Historical and projected data provide a reliable foundation for analysis.
- Professional Grade: Perfect for financial analysts, investors, and business consultants focusing on BALAMINESNS.
Who Should Use This Product?
- Investors: Assess Balaji Amines Limited's (BALAMINESNS) market valuation prior to trading decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
- Startup Founders: Gain insights into how established companies like Balaji Amines Limited are appraised.
- Consultants: Provide comprehensive valuation reports for your clientele.
- Students and Educators: Utilize actual data to practice and instruct on valuation strategies.
Contents of the Template
- Pre-Filled DCF Model: BALAMINESNS’s financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess BALAMINESNS’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your scenarios.
- Financial Statements: Annual and quarterly reports available for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.